Cornerstone Advisors (Washington)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-15,399
Closed -$1.23M 1166
2019
Q2
$1.23M Buy
15,399
+644
+4% +$49.3K 0.12% 22
2019
Q1
$1.17M Sell
14,755
-236
-2% -$17.7K 0.12% 24
2018
Q4
$1.09M Buy
14,991
+501
+3% +$35.4K 0.2% 23
2018
Q3
$981K Sell
14,490
-221
-2% -$14.1K 0.64% 23
2018
Q2
$852K Buy
14,711
+257
+2% +$14.5K 0.58% 28
2018
Q1
$751K Buy
14,454
+234
+2% +$12.6K 0.51% 26
2017
Q4
$764K Sell
14,220
-28
-0.2% -$1.55K 0.51% 25
2017
Q3
$870K Sell
14,248
-264
-2% -$16K 0.6% 21
2017
Q2
$887K Buy
14,512
+498
+4% +$30.3K 0.5% 20
2017
Q1
$850K Hold
14,014
0.46% 23
2016
Q4
$787K Buy
14,014
+1,636
+13% +$95.7K 0.66% 21
2016
Q3
$737K Buy
12,378
+7,296
+144% +$427K 0.62% 18
2016
Q2
$279K Buy
5,082
+47
+0.9% +$2.5K 0.28% 45
2016
Q1
$254K Sell
5,035
-319
-6% -$15.6K 0.27% 48
2015
Q4
$270K Buy
5,354
+411
+8% +$20.7K 0.3% 39
2015
Q3
$233K Buy
4,943
+162
+3% +$8.61K 0.2% 81
2015
Q2
$260K Hold
4,781
0.21% 81
2015
Q1
$262K Buy
4,781
+12
+0.3% +$679 0.2% 83
2014
Q4
$258K Buy
4,769
+143
+3% +$7.97K 0.19% 86
2014
Q3
$262K Sell
4,626
-50
-1% -$2.81K 0.21% 33
2014
Q2
$258K Hold
4,676
0.24% 38
2014
Q1
$253K Buy
4,676
+668
+17% +$34.6K 0.3% 31
2013
Q4
$191K Buy
4,008
+4
+0.1% +$183 0.27% 38
2013
Q3
$182K Buy
4,004
+3,697
+1,204% +$169K 0.31% 36
2013
Q2
$14K Buy
+307
New +$13.7K 0.03% 71

Other funds holding MRK

Cornerstone Advisors (Washington)'s MRK Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Merck (MRK) in Q3 2019, closing a stake of 15,399 shares — an estimated $1.23M sold.

Cornerstone Advisors (Washington) first reported a position in MRK in Q2 2013 and held it in 25 quarters. The position peaked at $1.23M in Q2 2019. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 15,399 Merck shares in Q3 2019, an estimated $1.23M.
  • Cornerstone Advisors (Washington) first reported a position in Merck in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s Merck position peaked at $1.23M in Q2 2019.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.